686 | Humans |
402 | Animals |
318 | Male |
312 | Female |
196 | Mice |
194 | Adult |
134 | Middle Aged |
83 | Adolescent |
82 | Aged |
73 | Disease Outbreaks |
72 | Mice, Inbred C57BL |
65 | Surveys and Questionnaires |
63 | Oxidative Stress |
63 | Cell Line |
61 | Influenza, Human (epidemiology) |
60 | Influenza, Human (prevention & control) |
58 | Orthomyxoviridae Infections (immunology) |
53 | Risk Factors |
53 | Influenza Vaccines (immunology) |
50 | Young Adult |
50 | Severe Acute Respiratory Syndrome (epidemiology) |
50 | Influenza A virus (immunology) |
49 | Severe Acute Respiratory Syndrome (psychology) |
45 | Time Factors |
45 | Stress, Psychological |
44 | Influenza, Human (virology) |
44 | Child |
43 | Pandemics |
43 | Influenza, Human (immunology) |
41 | Influenza, Human (complications) |
40 | Cells, Cultured |
39 | Mice, Inbred BALB C |
39 | Dogs |
38 | Influenza A Virus, H1N1 Subtype |
36 | Oxidative Stress (drug effects) |
36 | Orthomyxoviridae Infections (virology) |
36 | Aged, 80 and over |
35 | Stress, Psychological (immunology) |
35 | Stress, Physiological |
34 | Disease Models, Animal |
33 | Lung (virology) |
33 | Betacoronavirus |
32 | Lung (pathology) |
31 | Cross-Sectional Studies |
30 | Orthomyxoviridae Infections (metabolism) |
30 | Influenza, Human (metabolism) |
29 | Orthomyxoviridae Infections (pathology) |
28 | Signal Transduction |
28 | Reactive Oxygen Species (metabolism) |
28 | Pneumonia, Viral (psychology) |
28 | Coronavirus Infections (psychology) |
27 | Madin Darby Canine Kidney Cells |
27 | Host-Pathogen Interactions |
26 | Virus Replication |
26 | Stress, Psychological (psychology) |
26 | Influenza Vaccines (administration & dosage) |
26 | Influenza A virus |
26 | Influenza A virus (physiology) |
25 | Influenza A virus (genetics) |
25 | Coronavirus Infections (epidemiology) |
25 | Adaptation, Psychological |
24 | Stress, Physiological (immunology) |
24 | Prevalence |
24 | Pregnancy |
24 | Pneumonia, Viral (epidemiology) |
24 | Lung (metabolism) |
24 | Disease Outbreaks (prevention & control) |
23 | Stress, Psychological (complications) |
23 | Influenza A virus (pathogenicity) |
23 | Influenza A Virus, H1N1 Subtype (immunology) |
23 | Cell Line, Tumor |
22 | Influenza, Human (psychology) |
22 | Child, Preschool |
22 | Apoptosis |
21 | Stress, Psychological (epidemiology) |
21 | Orthomyxoviridae Infections (drug therapy) |
21 | Gene Expression Regulation |
21 | Antibodies, Viral (blood) |
21 | Age Factors |
20 | Stress Disorders, Post-Traumatic (epidemiology) |
20 | Severe Acute Respiratory Syndrome (prevention & control) |
20 | Orthomyxoviridae Infections (complications) |
20 | Models, Biological |
20 | Lung (immunology) |
20 | Influenza, Human (drug therapy) |
20 | Antiviral Agents (pharmacology) |
20 | Antioxidants (pharmacology) |
20 | Antioxidants (metabolism) |
19 | Treatment Outcome |
19 | Stress Disorders, Post-Traumatic (psychology) |
19 | Social Support |
19 | Severity of Illness Index |
19 | Health Personnel (psychology) |
19 | Health Knowledge, Attitudes, Practice |
19 | Gene Expression Profiling |
19 | Cytokines (metabolism) |
19 | Antiviral Agents (therapeutic use) |
18 | Vaccination |
18 | Temperature |
18 | Seasons |
18 | Oxidation-Reduction |
18 | Molecular Sequence Data |
18 | Chlorocebus aethiops |
17 | Virus Replication (drug effects) |
17 | Restraint, Physical |
17 | Phosphorylation |
17 | China (epidemiology) |
16 | Stress Disorders, Post-Traumatic (etiology) |
16 | Retrospective Studies |
16 | RNA, Messenger (metabolism) |
16 | Prospective Studies |
16 | Mice, Knockout |
16 | Influenza A virus (metabolism) |
16 | Hong Kong (epidemiology) |
16 | China |
16 | Blotting, Western |
15 | Stress, Psychological (etiology) |
15 | Stress Disorders, Post-Traumatic (diagnosis) |
15 | Reverse Transcriptase Polymerase Chain Reaction |
15 | RNA, Messenger (genetics) |
15 | Protein Binding |
15 | Mental Health |
15 | Life Change Events |
15 | Immunity, Innate |
15 | Follow-Up Studies |
15 | Epithelial Cells (virology) |
15 | Chickens |
15 | Attitude of Health Personnel |
15 | Analysis of Variance |
14 | Socioeconomic Factors |
14 | Lung (drug effects) |
14 | Influenza, Human (therapy) |
14 | Influenza, Human (pathology) |
14 | Influenza, Human (genetics) |
14 | Influenza A Virus, H1N1 Subtype (physiology) |
14 | HeLa Cells |
14 | HEK293 Cells |
14 | Gene Expression |
14 | Disaster Planning |
14 | Cohort Studies |
13 | eIF-2 Kinase (metabolism) |
13 | T-Lymphocytes (immunology) |
13 | Survival Analysis |
13 | Orthomyxoviridae Infections (veterinary) |
13 | Mutation |
13 | Mice, Inbred ICR |
13 | Influenza Vaccines (therapeutic use) |
13 | Influenza A Virus, H1N1 Subtype (pathogenicity) |
13 | Influenza A Virus, H1N1 Subtype (isolation & purification) |
13 | Infant |
13 | Incidence |
13 | Hot Temperature |
13 | Health Status |
13 | Health Behavior |
13 | A549 Cells |
12 | Virus Diseases (metabolism) |
12 | Viral Proteins (metabolism) |
12 | Viral Nonstructural Proteins (metabolism) |
12 | Sex Factors |
12 | Personnel, Hospital (psychology) |
12 | Orthomyxoviridae (immunology) |
12 | Nursing Staff, Hospital (psychology) |
12 | NF-kappa B (metabolism) |
12 | Influenza in Birds (epidemiology) |
12 | Health Surveys |
12 | Fear |
12 | Epithelial Cells (metabolism) |
12 | Corticosterone (blood) |
12 | Chronic Disease |
12 | Birds |
12 | Apoptosis (drug effects) |
12 | Antioxidants (therapeutic use) |
12 | Acute Disease |
11 | Workforce |
11 | Viral Load |
11 | Swine |
11 | Superoxide Dismutase (metabolism) |
11 | Stress, Physiological (physiopathology) |
11 | Severe Acute Respiratory Syndrome (transmission) |
11 | Severe Acute Respiratory Syndrome (therapy) |
11 | Orthomyxoviridae Infections (prevention & control) |
11 | Orthomyxoviridae Infections (genetics) |
11 | Killer Cells, Natural (immunology) |
11 | Influenza, Human (transmission) |
11 | Influenza, Human (diagnosis) |
11 | Influenza Vaccines |
11 | Influenza A virus (isolation & purification) |
11 | Influenza A Virus, H5N1 Subtype (pathogenicity) |
11 | Influenza A Virus, H1N1 Subtype (drug effects) |
11 | Heat-Shock Proteins (metabolism) |
11 | Global Health |
11 | Enzyme Activation |
11 | Disease Susceptibility |
11 | Caregivers (psychology) |
11 | CD8-Positive T-Lymphocytes (immunology) |
11 | Biomarkers (metabolism) |
11 | Antibodies, Viral (immunology) |
11 | Amino Acid Sequence |
11 | Aging (immunology) |
10 | Virus Diseases (immunology) |
10 | Vero Cells |
10 | Transcriptome |
10 | Transcription Factors (metabolism) |
10 | Superoxides (metabolism) |
10 | Stress, Physiological (complications) |
10 | Species Specificity |
10 | Signal Transduction (drug effects) |
10 | Severe Acute Respiratory Syndrome (nursing) |
10 | Severe Acute Respiratory Syndrome (complications) |
10 | Rats |
10 | Oxidative Stress (physiology) |
10 | Orthomyxoviridae Infections (physiopathology) |
10 | Multivariate Analysis |
10 | Medical Staff, Hospital (psychology) |
10 | Influenza, Human (physiopathology) |
10 | Influenza in Birds (virology) |
10 | Inflammation (pathology) |
10 | Hydrogen-Ion Concentration |
10 | Hong Kong |
10 | Endoplasmic Reticulum (metabolism) |
10 | Depression (psychology) |
10 | Depression (epidemiology) |
10 | Base Sequence |
9 | Virulence |
9 | Up-Regulation |
9 | United States |
9 | United States (epidemiology) |
9 | Toll-Like Receptor 4 (metabolism) |
9 | Taiwan (epidemiology) |
9 | Stress, Psychological (prevention & control) |
9 | Stress, Psychological (physiopathology) |
9 | Regression Analysis |
9 | Public Health |
9 | Proteome (metabolism) |
9 | Population Surveillance |
9 | Pneumonia, Viral (drug therapy) |
9 | Phylogeny |
9 | Phenotype |
9 | Orthomyxoviridae Infections (mortality) |
9 | Orthomyxoviridae (physiology) |
9 | Orthomyxoviridae (metabolism) |
9 | Oligonucleotide Array Sequence Analysis |
9 | Morbidity |
9 | Mental Disorders (epidemiology) |
9 | Lung (microbiology) |
9 | Influenza Vaccines (adverse effects) |
9 | Influenza A Virus, H5N1 Subtype |
9 | Inflammation |
9 | Hemagglutinin Glycoproteins, Influenza Virus (metabolism) |
9 | Emotions |
9 | Disease Outbreaks (veterinary) |
9 | Dietary Supplements |
9 | Data Collection |
9 | Cytokines (genetics) |
9 | Cold Temperature |
9 | Cell Phone |
9 | Antigens, Viral (immunology) |
8 | Vaccination (psychology) |
8 | T-Lymphocytes (metabolism) |
8 | Students (psychology) |
8 | Structure-Activity Relationship |
8 | Stress, Physiological (metabolism) |
8 | Schizophrenia (etiology) |
8 | Risk Assessment |
8 | Reactive Oxygen Species |
8 | RNA-Binding Proteins (metabolism) |
8 | RNA, Viral (metabolism) |
8 | Quarantine (psychology) |
8 | Pandemics (prevention & control) |
8 | Orthomyxoviridae |
8 | Orthomyxoviridae Infections (epidemiology) |
8 | Occupational Diseases (epidemiology) |
8 | Microwaves |
8 | Mice, Transgenic |
8 | Interviews as Topic |
8 | Interferon-gamma (biosynthesis) |
8 | Interferon-beta (metabolism) |
8 | Influenza, Human (mortality) |
8 | Influenza in Birds (prevention & control) |
8 | Influenza A virus (drug effects) |
8 | Influenza A Virus, H3N2 Subtype (immunology) |
8 | Inflammation (immunology) |
8 | Infection Control (methods) |
8 | Health Personnel (statistics & numerical data) |
8 | HSP70 Heat-Shock Proteins (metabolism) |
8 | Cytokines (immunology) |
8 | Cytokines (biosynthesis) |
8 | Cricetinae |
8 | Cell Nucleus (metabolism) |
8 | Cause of Death |
8 | Case-Control Studies |
8 | Brain (metabolism) |
8 | Attitude to Health |
8 | Anxiety (epidemiology) |
8 | Antioxidants (administration & dosage) |
8 | Antibody Formation (immunology) |
8 | Antibodies, Viral (biosynthesis) |
7 | Virus Diseases (etiology) |
7 | Viral Nonstructural Proteins (genetics) |
7 | Viral Envelope Proteins (metabolism) |
7 | Transcription, Genetic |
7 | Survivors (psychology) |
7 | Severe Acute Respiratory Syndrome (virology) |
7 | Risk |
7 | Respiratory Distress Syndrome, Adult (therapy) |
7 | Real-Time Polymerase Chain Reaction |
7 | Radio Waves |
7 | Prognosis |
7 | Practice Guidelines as Topic |
7 | Pneumonia (drug therapy) |
7 | Plant Extracts (pharmacology) |
7 | Orthomyxoviridae Infections (enzymology) |
7 | Nurses (psychology) |
7 | Mitogen-Activated Protein Kinases (metabolism) |
7 | Microscopy, Electron, Transmission |
7 | Membrane Proteins (metabolism) |
7 | Malondialdehyde (metabolism) |
7 | Macrophages (metabolism) |
7 | Lung (enzymology) |
7 | Logistic Models |
7 | Liver (metabolism) |
7 | Lipid Peroxidation |
7 | Lipid Peroxidation (drug effects) |
7 | Interleukin-6 (metabolism) |
7 | Interleukin-6 (blood) |
7 | Influenza, Human |
7 | Influenza A Virus, H5N1 Subtype (immunology) |
7 | Influenza A Virus, H1N1 Subtype (genetics) |
7 | Inflammation Mediators (metabolism) |
7 | Inflammation (metabolism) |
7 | Infectious Disease Transmission, Patient-to-Professional (prevention & control) |
7 | Immunologic Memory |
7 | Immunohistochemistry |
7 | Immune Tolerance (immunology) |
7 | Immobilization |
7 | Hemagglutinin Glycoproteins, Influenza Virus (immunology) |
7 | Hemagglutinin Glycoproteins, Influenza Virus (chemistry) |
7 | Health Personnel |
7 | Gene Knockdown Techniques |
7 | Fibroblasts (metabolism) |
7 | Europe (epidemiology) |
7 | Enzyme-Linked Immunosorbent Assay |
7 | Drug Stability |
7 | Down-Regulation |
7 | Dose-Response Relationship, Drug |
7 | Disease Transmission, Infectious (prevention & control) |
7 | Comorbidity |
7 | Canada (epidemiology) |
7 | CD4-Positive T-Lymphocytes (immunology) |
7 | Biomarkers |
7 | B-Lymphocytes (immunology) |
7 | Anxiety (psychology) |
7 | Antiviral Agents (metabolism) |
6 | Virus Replication (physiology) |
6 | Viral Proteins (chemistry) |
6 | Vaccines, Inactivated (immunology) |
6 | Vaccination (statistics & numerical data) |
6 | Vaccination (methods) |
6 | Vaccination (adverse effects) |
6 | Tumor Necrosis Factor-alpha (metabolism) |
6 | Stress, Psychological (metabolism) |
6 | Spectrometry, Fluorescence |
6 | Singapore (epidemiology) |
6 | Signal Transduction (physiology) |
6 | Severe Acute Respiratory Syndrome (metabolism) |
6 | SARS Virus (metabolism) |
6 | Respiratory Tract Infections (virology) |
6 | Respiratory Tract Infections (immunology) |
6 | Reference Values |
6 | Quarantine |
6 | Psychoneuroimmunology |
6 | Proteomics |
6 | Protein Transport |
6 | Protein Conformation |
6 | Prenatal Exposure Delayed Effects |
6 | Pneumonia, Viral (prevention & control) |
6 | Pneumonia, Viral (pathology) |
6 | Pneumonia (virology) |
6 | Oxidation-Reduction (drug effects) |
6 | Ontario |
6 | Nitric Oxide (metabolism) |
6 | Neutrophils (immunology) |
6 | Models, Molecular |
6 | Mitochondria (metabolism) |
6 | Mice, Inbred CBA |
6 | Mental Health Services |
6 | Macrophages (immunology) |
6 | Lymphocyte Activation (immunology) |
6 | Longitudinal Studies |
6 | Kinetics |
6 | Interleukin-2 (biosynthesis) |
6 | Interferon-gamma (metabolism) |
6 | Intensive Care Units |
6 | Influenza, Human (etiology) |
6 | Influenza, Human (blood) |
6 | Influenza Vaccines (chemistry) |
6 | Influenza B virus (immunology) |
6 | Influenza A Virus, H5N1 Subtype (genetics) |
6 | Infant, Newborn |
6 | Hot Temperature (adverse effects) |
6 | Host-Pathogen Interactions (immunology) |
6 | Horses |
6 | Homeostasis |
6 | Hemagglutinin Glycoproteins, Influenza Virus (genetics) |
6 | Glutathione (metabolism) |
6 | Germany |
6 | Flow Cytometry |
6 | Exercise (physiology) |
6 | Drugs, Chinese Herbal (pharmacology) |
6 | Disasters |
6 | Diet |
6 | Decision Making |
6 | Coronavirus |
6 | Coronavirus Infections (prevention & control) |
6 | Cold Temperature (adverse effects) |
6 | Chick Embryo |
6 | Cell Survival |
6 | Cattle |
6 | Catalase (metabolism) |
6 | Caspases (metabolism) |
6 | Caregivers |
6 | Biomarkers (blood) |
6 | Binding Sites |
6 | Autophagy |
6 | Antibody Formation |
6 | Antibodies, Viral (analysis) |
6 | Acute Lung Injury (drug therapy) |
5 | Virus Diseases (virology) |
5 | Virus Diseases (complications) |
5 | Viral Proteins (genetics) |
5 | Universities |
5 | Transcription Factors (genetics) |
5 | Taiwan |
5 | T-Lymphocyte Subsets (immunology) |
5 | Survival Rate |
5 | Stress, Psychological (therapy) |
5 | Stress, Psychological (diagnosis) |
5 | Social Isolation |
5 | Smoking (adverse effects) |
5 | Sex Characteristics |
5 | Selenium (deficiency) |
5 | Schizophrenia (epidemiology) |
5 | Saliva (chemistry) |
5 | SARS Virus |
5 | SARS Virus (physiology) |
5 | SARS Virus (genetics) |
5 | Respiratory Tract Infections (psychology) |
5 | Rats, Sprague-Dawley |
5 | Radiation Dosage |
5 | RNA-Binding Proteins (genetics) |
5 | Quality of Life |
5 | Qualitative Research |
5 | Psychophysiologic Disorders (psychology) |
5 | Psychiatric Status Rating Scales |
5 | Proteins (metabolism) |
5 | Protein Biosynthesis |
5 | Pneumonia, Viral (therapy) |
5 | Pneumonia, Viral (metabolism) |
5 | Pneumonia, Viral (complications) |
5 | Pneumonia (etiology) |
5 | Phytotherapy |
5 | Orthomyxoviridae Infections (psychology) |
5 | Orthomyxoviridae Infections (etiology) |
5 | Orthomyxoviridae (genetics) |
5 | Ontario (epidemiology) |
5 | Occupational Health |
5 | Occupational Exposure |
5 | Occupational Diseases (psychology) |
5 | Occupational Diseases (etiology) |
5 | NF-E2-Related Factor 2 (metabolism) |
5 | NADPH Oxidases (metabolism) |
5 | Molecular Structure |
5 | Models, Theoretical |
5 | Mitochondria (drug effects) |
5 | Military Personnel |
5 | Mifepristone (pharmacology) |
5 | Mice, Inbred DBA |
5 | Mental Disorders (etiology) |
5 | Mass Media |
5 | Macrophages (drug effects) |
5 | Lymphocyte Activation |
5 | Lung (cytology) |
5 | Light |
5 | Japan |
5 | Internet |
5 | Influenza, Human (enzymology) |
5 | Influenza Vaccines (genetics) |
5 | Influenza A Virus, H5N1 Subtype (physiology) |
5 | Influenza A Virus, H1N1 Subtype (metabolism) |
5 | Influenza A Virus, H1N1 Subtype (growth & development) |
5 | Host-Pathogen Interactions (genetics) |
5 | Hospitalization (statistics & numerical data) |
5 | Heat Stress Disorders (mortality) |
5 | Gene Expression Regulation (drug effects) |
5 | France (epidemiology) |
5 | Evolution, Molecular |
5 | Epithelial Cells (enzymology) |
5 | Endoplasmic Reticulum Stress |
5 | Endoplasmic Reticulum Stress (genetics) |
5 | Emergency Service, Hospital |